MedPath

Pressure Ulcer Incidence Cat. II+ on a Static Air Mattress: a Multicenter Cohort Study in Nursing Home Residents at Risk

Not Applicable
Completed
Conditions
Pressure Injury
Pressure Sore
Pressure Ulcer
Bed Sore
Interventions
Device: CuroCell S.A.M. ® pro mattress
Registration Number
NCT03725787
Lead Sponsor
University Ghent
Brief Summary

Pressure Ulcers are a serious and common problem for residents admitted to long-term care facilities and community care patients. They represent a major burden to patients, carers and the Healthcare system, affecting approximately 1 in 20 community patients. International guidelines recommend the use of pressure redistribution support surfaces, systematic patient repositioning and preventive skin care to prevent pressure ulcers.

It has been acknowledged that a significant proportion of pressure ulcers are avoidable. The prevalence of pressure ulcers is 1 of the 4 common harms recorded in the UK NHS Safety Thermometer, a local improvement tool for measuring, monitoring and analyzing patient harms across a range of settings, including nursing homes, community nursing and hospitals on a monthly basis.

Static or reactive overlay mattresses are an example of a low-tech constant low-pressure support. Static air mattresses maintain a continuous low air pressure that exerts a pressure redistributing effect. Serraes and Beeckman found a pressure ulcer incidence of 5.1% in patients placed on static air support (mattress overlay, heel wedge and seat cushion) in a high risk population in a nursing home setting in Belgium.

The CuroCell SAM PRO (Care of Sweden AB) is a static air mattress overlay system used as prevent and treat pressure ulcers (up to category 3) and for pain therapy. The aim of current study is to measure pressure ulcer incidence on the CuroCell Sam PRO static air mattress in nursing home residents at risk for pressure ulcer development over a 30-day period in Belgium.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
180
Inclusion Criteria
  • At risk of pressure ulcer development based on a Braden score ≤ 17
  • Bedbound or chair bound
  • Aged ≥ 65
Exclusion Criteria
  • Short-stay residents (expected length of stay ≤14 days)
  • End of life care
  • Medical contraindication for patient repositioning/turning
  • Pressure ulcer Cat. II+ present on initial evaluation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
CuroCell S.A.M. ® pro mattressCuroCell S.A.M. ® pro mattressMattresses of eligible participants will be replaced by a static air pressure redistribution mattress (CuroCell S.A.M. ® Pro).
Primary Outcome Measures
NameTimeMethod
Pressure ulcer incidence (Cat. II+), (NPUAP classification system)30 days

Development of at least 1 pressure ulcer Cat. II+ during study period, not associated with the use of medical devices

Secondary Outcome Measures
NameTimeMethod
Incidence rate of Cat. I pressure ulcers, (NPUAP classification system)30 days

Development of at least 1 pressure ulcer Cat. I during study period, not associated with the use of medical devices

Comfort of participants (self developed questionnaire)30 days

A quantitative approach to obtain insight in residents' experiences and perceptions of comfort by using a questionnaire

Trial Locations

Locations (7)

Provinciaal Zorgcentrum Lemberge

🇧🇪

Merelbeke, Oost-Vlaanderen, Belgium

WZC Sint-Rafaël

🇧🇪

Liedekerke, Vlaams-Brabant, Belgium

WZC Sint-Jozef

🇧🇪

Gent, Oost-Vlaanderen, Belgium

WZC Brugse Vaart

🇧🇪

Mariakerke, Oost-Vlaanderen, Belgium

Residentie Vroonstalle

🇧🇪

Wondelgem, Oost-Vlaanderen, Belgium

WZC Sint-Vincentius

🇧🇪

Kaprijke, Oost-Vlaanderen, Belgium

WZC Onderdale

🇧🇪

Ursel, Oost-Vlaanderen, Belgium

© Copyright 2025. All Rights Reserved by MedPath